Exp Clin Endocrinol Diabetes 2012; 120(10): 567-572
DOI: 10.1055/s-0032-1321786
Article
© Georg Thieme Verlag KG Stuttgart · New York

Early Pancreas Transplant Improves Motor Nerve Conduction in Alloxan-Induced Diabetic Rats

C. T. Spadella
1   Research was performed at the Department of Surgery and Orthopedics and Department of Neurology, ­Faculty of ­Medicine – São Paulo State University – UNESP, Botucatu, São Paulo, Brazil
,
A. N. Lucchesi
1   Research was performed at the Department of Surgery and Orthopedics and Department of Neurology, ­Faculty of ­Medicine – São Paulo State University – UNESP, Botucatu, São Paulo, Brazil
,
S. Alberti
1   Research was performed at the Department of Surgery and Orthopedics and Department of Neurology, ­Faculty of ­Medicine – São Paulo State University – UNESP, Botucatu, São Paulo, Brazil
,
L.A. L. Resende
1   Research was performed at the Department of Surgery and Orthopedics and Department of Neurology, ­Faculty of ­Medicine – São Paulo State University – UNESP, Botucatu, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

received 18 January 2012
first decision 25 May 2012

accepted 22 June 2012

Publication Date:
22 November 2012 (online)

Abstract

The purpose of this study was to assess the temporal relationship between pancreas transplant and the development of electrophysiological changes in the sciatic and caudal nerves of alloxan-induced diabetic rats. Nerve conduction studies were performed in diabetic rats subjected to pancreas transplantation at 4, 12, and 24 weeks after diabetes onset, using non-diabetic and untreated diabetic rats as controls. Nerve conduction data were significantly altered in untreated diabetic control rats up to 48 weeks of follow-up in all time points. Rats subjected to pancreas transplantation up to 4 and 12 weeks after diabetes onset had significantly increased motor nerve conduction velocity with improvement of wave amplitude, distal latency, and temporal dispersion of compound muscle action potential in all follow-up periods (P<0.05); these parameters remained abnormal when pancreas transplantation were performed late at 24 weeks. Our results suggest that early pancreas transplant (at 4–12 weeks) may be effective in controlling diabetic neuropathy in this in vivo model.

 
  • References

  • 1 Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88 (11) 1254-1264
  • 2 Tesfaye S, Boulton AJ, Dyck PJ et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33 (10) 2285-2293
  • 3 Boulton AJ, Malik RA. Diabetic neuropathy. Med Clin North Am 1998; 82 (04) 909-929
  • 4 Sima AAF, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 1999; 42 (07) 773-778
  • 5 Sima AA, Zhang W, Grunberger G. Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res 2004; 5 (01) 65-77
  • 6 Siperstein MD. Diabetic microangiopathy and the control of blood glucose. N Engl J Med 1983; 309 (25) 1577-1579
  • 7 Unger RH. Benefits and risks of meticulous control of diabetes. Med Clin North Am 1982; 66 (06) 1917-1924
  • 8 The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329 (14) 977-986
  • 9 Dieterle CD, Arbogast H, Ilner WD et al. Metabolic follow-up after long-term pancreas graft survival. Eur J Endocrinol 2007; 156 (05) 603-610
  • 10 Lauria MW, Figueiró JM, Machado LJ et al. Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations. Transplantation 2010; 89 (01) 83-87
  • 11 Brismar T, Sima AA, Greene DA. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 1987; 21 (05) 504-507
  • 12 Boucek P. Advanced diabetic neuropathy: A point of no return?. Rev Diabet Stud 2006; 3 (03) 143-150
  • 13 Yasuda H, Terada M, Maeda K et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003; 69 (04) 229-285
  • 14 Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005; 10 (02) 144-157
  • 15 Lee S, Tung KS, Koopmans H et al. Pancreaticoduodenal transplantation in the rat. Transplantation 1972; 13 (04) 421-425
  • 16 Spadella CT, Mercadante MC, Machado JL et al. Microsurgical pancreatoduodenal transplantation in rats. Technique and results following 12 years of investigation. Arq Gastroenterol 1996; 33 (03) 158-166
  • 17 The Diabetes Control and Complications Trial Research Group . The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Inter Med 1995; 122 (08) 561-568
  • 18 Parry GJ. Management of diabetic neuropathy. Am J Med 1999; 107 (2B) 27S-33S
  • 19 Orloff MJ, Greenleaf GE, Girard B. Reversal of diabetic somatic neuropathy by whole-pancreas transplantation. Surgery 1990; 108 (02) 179-189
  • 20 Solders G, Tydén G, Persson A et al. Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 1992; 41 (08) 946-951
  • 21 Navarro X, Kennedy WR. Effects of pancreas transplantation on secondary complications of diabetes. Neuropathy. In: Gruessner RW, Sutherland DE. (eds.). Transplantation of the pancreas. New York: Springer; 2004: 83-496
  • 22 Sima AA, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 1999; 42 (07) 773-788
  • 23 Boulton AJ, Malik RA, Arezzo JC et al. Diabetic somatic neuropathies. Diabetes Care 2004; 27 (06) 1458-1486
  • 24 Machado JLM, Macedo AR, Silva MD et al. Characterization of an experimental model of neuropathy in alloxan-induced diabetic rats. Acta Cir Bras 2000; 15 (02) 86-93 Available from: URL http://dx.doi.org/10.1590/S0102-86502000000200003
  • 25 Macedo AR, Skivolocki WP, Thompson KR et al. Morphometric electron microscopic study of the effect of whole pancreas transplantation on alloxan diabetic neuropathy. Surg Forum 1981; 2: 379-380
  • 26 Müller-Felber W, Landgraf R, Scheuer R et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993; 42 (10) 1482-1486
  • 27 Navarro X, Sutherland DER, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997; 42 (05) 727-736
  • 28 Recasens M, Ricart MJ, Valls-Solé J et al. Long-term follow-up of diabetic polineuropathy after simultaneous pancreas and kidney transplantation in type 1 diabetic patients. Transpl Proc 2002; 34 (01) 200-203
  • 29 Spadella CT, Machado JL, Lerco MM et al. Temporal relationship between successful pancreas transplantation and control of ocular complications in alloxan-induced diabetic rats. Transplant Proc 2008; 40 (02) 518-523
  • 30 Scott MH, Lee S, D'Silva M et al. Effect of pancreas allografts on the ultrastruture of sciatic nerves in diabetic rats. Microsurgery 1990; 11 (02) 152-161
  • 31 Allen RD, Al-Harbi IS, Morris JG et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997; 63 (06) 830-838